The United States Food and Drug Administration (FDA) published Thursday a list of pharmaceutical companies that include Basel-based Novartis and Roche, all of which are suspected of hindering the development of generic versions of their own medicines. Over 150 complaints were filed.
The FDA slammed the development of techniques designed to complicate or even prevent developers of generic drugs from accessing sufficient quantities of original preparations to be able to do comparative studies essential to any application for approval.
The authority said it has received more than 150 complaints over the alleged misuse of FDA programmes or agreements between pharmaceutical companies and distributors.
The FDA noted that it had not investigated these allegations.
SDA-ATS/ds
Popular Stories
More
Life & Aging
Zurich: how the world capital of housing shortages is tackling the problem
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
Lufthansa set to abolish in-flight sales, SWISS to keep them
This content was published on
Perfumes, cigarettes, sunglasses: The German airline Lufthansa will no longer sell these products on long-haul flights in future. Lufthansa subsidiary Swiss is sticking to in-flight sales for the time being.
This content was published on
After a short break due to the cool weather, grass pollen is now flying in Switzerland, the Swiss Allergy Centre said on Monday.
This content was published on
Researchers have shown for the first time in Switzerland that urban greenery measurably reduces the stress levels of city dwellers.
US tariffs affect canton Zurich less than other locations
This content was published on
The Zurich cantonal government is observing the developments surrounding the US tariffs "with concern". Compared to other locations, however, Zurich should get off lightly.
This content was published on
The Alpine Museum in Bern is showing the finds of diver David Godio, who has been fishing lost objects out of the River Aare for years.
This content was published on
Healthcare costs in Switzerland rose by 2.4% in 2023. The Swiss healthcare system thus cost around CHF94 billion ($113 billion).
Karaoke tram to run through Basel during Eurovision
This content was published on
A karaoke tram will be doing the rounds in Basel during the Eurovision Song Contest (ESC). During a 90-minute journey, guests can sing and dance for free in a vintage car.
Net wealth of Swiss households rises to CHF4.8 trillion
This content was published on
Private household assets in Switzerland continued to grow strongly in 2024. The increase was driven by both the growth in financial assets and higher property assets.
This content was published on
Each year, some half a million people die of malaria, many of them children. Switzerland is a world leader in research to combat the disease.
Swiss authorities allowed isopropanol exports to Syria
This content was published on
Switzerland authorised the export to Syria of the chemical isopropanol in 2014, which can be used to make sarin gas, RTS, reports.
Novartis and GSK CEOs set out diverging strategies
This content was published on
It is a tale of two newly minted chief executives, each looking to send a clear signal to investors about strategy and priorities.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.